Insider Trading activities of Soligenix, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Soligenix, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Soligenix, Inc. since year 2005. Table 2 shows the detailed insider transactions of Soligenix, Inc. since 2005. The reporting company's ticker symbol is SNGX. The reporting company's CIK number is 812796.
The total value of stock buying since 2005 is $23,803,236.
The total value of stock sales since 2005 is $1,343,078.
The total value of stock option exercises since 2005 is $117,039.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Soligenix, Inc. (SNGX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-08 3,530 $5,012 0 $0 0 $0
2017-11 293,510 $622,241 293,510 $622,241 0 $0
2017-05 0 $0 160,968 $472,182 0 $0
2016-12 20,969 $66,261 0 $0 0 $0
2015-12 12,500 $16,055 0 $0 0 $0
2015-08 0 $0 0 $0 25,000 $7,500
2015-07 0 $0 0 $0 7,143 $4,357
2015-04 0 $0 0 $0 32,143 $19,606
2014-12 16,530 $20,000 0 $0 0 $0
2014-08 0 $0 0 $0 7,500 $15,074
2014-05 0 $0 0 $0 29,172 $13,002
2013-06 52,379 $54,997 0 $0 25,000 $7,500
2012-04 9,900 $5,049 0 $0 0 $0
2010-08 160,000 $38,400 192,314 $46,155 0 $0
2010-06 29,972,081 $6,144,273 0 $0 0 $0
2009-09 11,936,758 $3,019,996 0 $0 0 $0
2009-08 0 $0 500,000 $100,000 0 $0
2009-07 0 $0 500,000 $102,500 0 $0
2009-02 75,000,000 $13,500,000 0 $0 0 $0
2007-08 205,000 $60,954 0 $0 0 $0
2007-02 531,914 $249,998 0 $0 0 $0
2006-01 0 $0 0 $0 250,000 $50,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Soligenix, Inc. insiders (SNGX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-08-22 Schaber Christopher J (Chairman, CEO and President) Buy 3,530 1.42 5,012
2017-11-29 Cavazza Preta Martina Buy 293,510 2.12 622,241
2017-11-29 Cavazza Preta Martina Sale 293,510 2.12 622,241
2017-05-08 Intrexon Corp Sale 11,576 2.54 29,403
2017-05-05 Intrexon Corp Sale 85,500 2.70 230,850
2017-05-04 Intrexon Corp Sale 63,892 3.32 211,929
2016-12-16 Brughera Marco Maria Buy 2,000 3.16 6,320
2016-12-16 Rubin Robert J. Buy 3,165 3.16 10,001
2016-12-16 Schaber Christopher J (Chairman, CEO and President) Buy 15,804 3.16 49,940
2015-12-23 Zeldis Jerome B Buy 2,500 1.27 3,175
2015-12-22 Schaber Christopher J (Chairman, CEO and President) Buy 10,000 1.29 12,880
2015-08-31 Lapointe Anthony Gregg Option Ex 25,000 .30 7,500
2015-07-01 Schaber Christopher J (Chairman, CEO and President) Option Ex 7,143 .61 4,357
2015-04-09 Brownlie Keith L Option Ex 14,286 .61 8,714
2015-04-09 Zeldis Jerome B Option Ex 17,857 .61 10,892
2014-12-22 Warusz Joseph Michael (VP of Finance/Acting CFO) Buy 8,265 1.21 10,000
2014-12-22 Schaber Christopher J (Chairman, CEO and President) Buy 8,265 1.21 10,000
2014-08-05 Brughera Marco Maria Option Ex 7,500 2.01 15,074
2014-05-19 Warusz Joseph Michael (VP of Admin, Controller / PAO) Option Ex 4,690 .64 3,001
2014-05-14 Brownlie Keith L Option Ex 16,667 .30 5,000
2014-05-13 Schaber Christopher J (Chairman, CEO and President) Option Ex 7,815 .64 5,001
2013-06-25 Brownlie Keith L Buy 19,047 1.05 19,999
2013-06-25 Zeldis Jerome B Buy 23,809 1.05 24,999
2013-06-25 Schaber Christopher J (Chairman, CEO and President) Buy 9,523 1.05 9,999
2013-06-20 Zeldis Jerome B Option Ex 25,000 .30 7,500
2012-04-10 Schaber Christopher J (Chairman CEO and President) Buy 9,900 .51 5,049
2010-08-18 Mintz Hal Buy 160,000 .24 38,400
2010-08-18 Mintz Hal Sale 192,314 .24 46,155
2010-06-18 Rubin Robert J. Buy 243,902 .20 49,999
2010-06-18 Sigma-tau Pharmaceuticals, Inc. Buy 8,608,580 .20 1,764,758
2010-06-18 Lapointe Anthony Gregg Buy 975,610 .20 200,000
2010-06-18 Cavazza Claudio Buy 8,608,580 .20 1,764,758
2010-06-18 Cavazza Paolo Buy 11,535,409 .20 2,364,758
2009-09-28 Schaber Christopher J (Chief Executive Officer) Buy 79,051 .25 19,999
2009-09-24 Sigma-tau Pharmaceuticals, Inc. Buy 3,952,569 .25 999,999
2009-09-24 Cavazza Claudio Buy 3,952,569 .25 999,999
2009-09-24 Cavazza Paolo Buy 3,952,569 .25 999,999
2009-08-11 Biotex Pharma Investments, Llc (10% Owner) Sale 500,000 .20 100,000
2009-07-30 Biotex Pharma Investments, Llc (10% Owner) Sale 500,000 .20 102,500
2009-02-11 Sigma-tau Pharmaceuticals, Inc. Buy 25,000,000 .18 4,500,000
2009-02-11 Cavazza Claudio Buy 25,000,000 .18 4,500,000
2009-02-11 Cavazza Paolo Buy 25,000,000 .18 4,500,000
2007-08-29 Myrianthopoulos Evan (Chief Financial Officer) Buy 70,000 .31 21,630
2007-08-28 Clavijo James (Controller/Treasurer) Buy 35,000 .29 10,325
2007-08-28 Schaber Christopher J (Chief Executive Officer) Buy 100,000 .29 28,999
2007-02-09 Clavijo James (Controller/Treasurer) Buy 53,191 .47 24,999
2007-02-09 Kanzer Steve H Buy 212,766 .47 100,000
2007-02-09 Schaber Christopher J (Chief Executive Officer) Buy 212,766 .47 100,000
2007-02-09 Myrianthopoulos Evan (Chief Financial Officer) Buy 53,191 .47 24,999
2006-01-20 Kanzer Steve H Option Ex 250,000 .20 50,000

Insider trading activities including stock purchases, stock sales, and option exercises of SNGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Soligenix, Inc. (symbol SNGX, CIK number 812796) see the Securities and Exchange Commission (SEC) website.